Bank Of America Corp Connect Biopharma Holdings LTD Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.82 - $1.32 $8 - $13	-10 Reduced 83.33%	2 $0
Q4 2022 Feb 10, 2023	SELL	$0.64 - $1.31 $51 - $106	-81 Reduced 87.1%	12 $0
Q3 2022 Nov 14, 2022	SELL	$0.8 - $1.65 $327 - $674	-409 Reduced 81.47%	93 $0
Q2 2022 Aug 12, 2022	SELL	$0.56 - $3.25 $165,555 - $960,810	-295,634 Reduced 99.83%	502 $0
Q1 2022 May 16, 2022	BUY	$2.46 - $5.92 $22,157 - $53,321	9,007 Added 3.14%	296,136 $894,000
Q4 2021 Feb 08, 2022	BUY	$4.26 - $23.33 $1.19 Million - $6.49 Million	278,359 Added 3173.99%	287,129 $1.48 Million
Q3 2021 Nov 15, 2021	BUY	$18.12 - $28.5 $158,912 - $249,945	8,770 New	8,770 $212,000

3.03M

Ticker CNTB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,015,800
Market Cap $55.6M
Description
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.